- Report
- May 2025
- 267 Pages
Global
From €4351EUR$4,950USD£3,763GBP
- Report
- October 2024
- 122 Pages
Global
From €4087EUR$4,650USD£3,535GBP
- Report
- March 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- August 2025
- 197 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- February 2025
- 180 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- September 2025
- 282 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 220 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- May 2025
- 114 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- September 2025
- 421 Pages
Global
From €6148EUR$6,995USD£5,318GBP
- Report
- November 2024
- 120 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- May 2025
- 100 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- March 2025
- 200 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- August 2025
- 180 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- April 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- November 2024
- 338 Pages
Global
From €4395EUR$5,000USD£3,801GBP
- Report
- June 2025
- 182 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- September 2025
- 174 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1758EUR$2,000USD£1,521GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,266USD£3,133GBP
- Report
- May 2025
- 450 Pages
Global
From €3512EUR$3,995USD£3,037GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more